| Bladder Urothelial Carcinoma studied in …STUDIED_INderived138 of 138show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Invasive Bladder Giant Cell Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061964Phase 2 · recruiting Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06770582Phase 2 · recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605404recruiting Pan-tumor MRD Study · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04963153Phase 1 · active not recruiting Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332351Phase 2 · not yet recruiting Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04579224Phase 3 · active not recruiting Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940299Phase 2 · active not recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822373Phase 2 · not yet recruiting A Phase 2 Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06503614Phase 2 · recruiting A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00365157Phase 1/Phase 2 · active not recruiting Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189793Phase 2 · not yet recruiting Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07414992Phase 2 · withdrawn A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03244384Phase 3 · active not recruiting Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03775265Phase 3 · active not recruiting Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097142Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07726602recruiting Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164082Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Flat Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07756008Phase 2/Phase 3 · not yet recruiting Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01050504recruiting Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05483868Phase 1 · active not recruiting A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06809140Phase 2 · recruiting Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03047213Phase 2 · active not recruiting Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03237780Phase 2 · active not recruiting Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07725796Phase 1 · not yet recruiting A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07717242Phase 2 · recruiting Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05833867Phase 1 · recruiting Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03744793Phase 2 · active not recruiting Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521698Phase 1 · recruiting A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302230NA · recruiting Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942331Phase 3 · completed Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092958Phase 3 · active not recruiting Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06630416Phase 2 · recruiting Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07029256recruiting Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB) · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02717156Phase 2 · active not recruiting Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216290Phase 2 · active not recruiting A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06204614early Phase 1 · enrolling by invitation Drug Screening Using IMD in Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03601455Phase 2 · active not recruiting Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07087860Phase 2 · recruiting Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07231809NA · not yet recruiting Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04878029Phase 1 · recruiting Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Invasive Bladder Urothelial Carcinoma with Squamous Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07353294Phase 1 · enrolling by invitation Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05700227NA · terminated Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04953104Phase 2 · active not recruiting ARID1A and/or KDM6A Mutation and CXCL13 Expression · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03609216Phase 2 · active not recruiting Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03091660Phase 3 · active not recruiting S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637594Phase 3 · active not recruiting Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06349642recruiting Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01616875Phase 2 · completed Bristol Bladder Trial · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848519Phase 2 · active not recruiting Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07234968NA · recruiting Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764095Phase 4 · recruiting Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02989064Phase 1 · completed MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06818136recruiting Bladder EpiCheck European Haematuria Study · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05375903Phase 1 · completed A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05962541Phase 4 · recruiting Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07279597Phase 2 · not yet recruiting A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263153Phase 2 · recruiting Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582475Phase 1 · active not recruiting Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06396533recruiting Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564416Phase 2 · withdrawn Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01495676NA · terminated A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985604Phase 2 · terminated Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05296564Phase 1/Phase 2 · recruiting Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06727214not yet recruiting Survival Benefits of Neoadjuvant Systemic Chemotherapy in Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03039413early Phase 1 · completed Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04570410Phase 2 · completed Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04574960Phase 3 · recruiting Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064863Phase 1/Phase 2 · not yet recruiting A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563272Phase 2 · terminated 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05788484Phase 1 · completed A Study of CDX-585 in Patients With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02844816Phase 2 · completed Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06257017Phase 2 · recruiting Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06766266Phase 1 · recruiting Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567409Phase 2 · completed Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02202772Phase 1/Phase 2 · active not recruiting Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06818799NA · completed Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03473730early Phase 1 · completed Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04167631NA · active not recruiting Can VI-RADS/ADC Accurately Stage Bladder Cancer?? · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012397Phase 2 · terminated Milademetan in Advanced/Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05215574Phase 1 · active not recruiting Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06550947unknown ALDOA Expression in Bladder Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528483Phase 2 · not yet recruiting Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03513952Phase 2 · completed Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02808143Phase 1 · completed Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06416319NA · unknown Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05311618Phase 1 · unknown Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03329950Phase 1 · completed A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04200963Phase 1 · completed A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03549715Phase 1/Phase 2 · unknown NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04492293Phase 2 · unknown An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04496219Phase 2 · completed Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06170177recruiting Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06167356recruiting Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03912818Phase 2 · terminated Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06020807completed Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03421652Phase 2 · completed Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05946369completed Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04440943Phase 1 · completed A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05833997NA · unknown Safety Analysis and Oncological Outcomes in HoLERT vs TURBT · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03854721Phase 1 · completed A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052372terminated Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02437370Phase 1 · completed Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04972253Phase 1 · withdrawn Phase I BLASST-3 Trial · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02901548Phase 2 · terminated Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05139134unknown Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238420Phase 1/Phase 2 · completed Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03266900early Phase 1 · terminated A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05220124Phase 4 · unknown A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03715985Phase 1/Phase 2 · unknown Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac) · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02767921Phase 1 · terminated sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730232Phase 2 · unknown Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05027412NA · unknown En Bloc TURBT With Collins Loop vs Conventional TURBT · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04647981completed Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test. · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113266Phase 2 · unknown Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00749892Phase 2 · completed Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688348NA · withdrawn Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03335059Phase 3 · terminated Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935347Phase 2 · withdrawn Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02178241Phase 2 · completed Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04129606NA · unknown Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02494635terminated Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02699853NA · terminated Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03419130Phase 2 · withdrawn Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02514408withdrawn Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03238664NA · withdrawn Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02944357NA · withdrawn Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03138824NA · unknown Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01522820Phase 1 · completed Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02718742Phase 2 · withdrawn Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01599013Phase 2 · completed JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin · condition mapped CURATED_BROADER · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072137Phase 1 · terminated Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01304173completed Retrospective Chart Review of Valstar · condition mapped ALIAS · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01968928unknown The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 138 trials mapped (70 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |